---
$id: https://graph.org.ai/products/commodity/51283604
$type: Product
source: UNSPSC
code: "51283604"
title: "Rifaximin"
class: "51283600"
classTitle: "Rifamycin antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rifaximin

**UNSPSC Code**: 51283604
**Class**: [Rifamycin antibacterials](Rifamycin antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L36O5T016N. European Medicines Agency schedules Rifaximin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10312MIG. Rifaximin generally arises in the molecular formula C43H51N3O11. The term RIFAXIMIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, no. 6, 1983, list 23.) RIFAXIMIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rifaximin under HS 29419000 and SITC 54139. As of Q4 2014, RIFAXIMIN remains the US FDA Preferred Term for this commodity. Rifaximin bears US NLM identifiers UMLS ID C0073374 and NCI Concept Code C61926. SMILES: O(C1C(C(O)C(C(O)C(C)C=CC=C(C(=O)NC2C3N4C(NC3C3C5C(OC(OC=CC(OC)C1C)(C5=O)C)C(C(O)C3C2O)C)CC(CC4)C)C)C)C)C(=O)C.

